Jobs / United States / Glaxosmithkline LLC
AI Transformation & Enablement Associate Director
Glaxosmithkline LLC · 🇺🇸 GSK HQ
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles4 certified filings for “Associate Director – Genomic Technologies” (Molecular and Cellular Biologists) in PA: $134k–$138k, median $136k. Most were filed at wage level IV (50%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
Help shape the future of clinical development through AI GSK’s Development Operations Platforms & Innovation team is building the capabilities needed to deploy AI at scale across clinical operations. We are looking for an AI Transformation and Enablement Associate Director to turn agentic AI into practical, measurable improvements in how clinical trials are planned, delivered and continuously improved. Reporting to the Head of Asset Acceleration and AI, you will lead the transformation programme, enable colleagues to use frontier AI tools effectively, and oversee the portfolio that turns promising ideas and workflows into scalable solutions In this role you will • Define and deliver the agentic AI strategy and multi-year roadmap for Development Operations. • Drive adoption of AI tools across teams through training, communications, launch readiness and a Champion Network. • Evaluate frontier, open-weight and locally run AI models, balancing effectiveness, cost, quality and compliant deployment. • Own the Development Operations skills and workflow library, setting standards and enabling teams to build safely. • Identify high-value workflows and partner with technical teams to move the strongest solutions into production. • Lead delivery of the AI portfolio, managing priorities, milestones, dependencies, risks and governance. • Measure value through outcomes such as adoption, quality, cycle time and readiness to scale. • Work with functional leaders to redesign processes, roles and ways of working around the opportunities created by AI. Why you? Basic Qualifications : We are looking for professionals with these required skills to achieve our goals: • A bachelor’s degree in life sciences, engineering, computer science, business or a related field. • Experience in pharmaceutical strategy, applied AI or technology, transformation, programme delivery, consulting or a comparable venture-building environment. • A strong understanding of pharmaceutical clinical development. • Practical knowledge of agentic AI systems, including context, memory, tool use, orchestration, evaluation and reliability. • Hands-on experience using frontier agentic development tools, rapidly prototyping solutions and evaluating their value against a baseline. • Experience taking a new technology or way of working from early adoption to routine use across a distributed organisation. • Strong programme or portfolio management experience, including multiple workstreams, governance, dependencies and risk. • Experience working in a regulated environment. • Excellent communication skills, with the ability to explain complex technical and strategic topics to senior, non-technical audiences. Preferred Skills : If you have the following characteristics, it would be a plus: · An advanced degree in a relevant discipline. · Evidence of independently building AI skills, agents, tools or prototypes. · Hands-on clinical operations experience and an understanding of GxP expectations. · Experience translating technology adoption into meaningful changes to processes, roles or operating models. Closing Date for Applications: Monday 5 th October 2026 (COB) Please take a copy of the Job Description, as this will not be available post closure of the advert. When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application. During the course of your application, you will be requested to complete voluntary information which will be used in monitoring the effectiveness of our equality and